Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Yingling Zu"'
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2024)
Abstract Background Chimeric antigen receptor engineered T cells (CAR-T) have demonstrated promising clinical efficacy in B-cell malignancies, and the approach has been extended to T-cell malignancies. However, the use of allogeneic T cells in CAR th
Externí odkaz:
https://doaj.org/article/e5444ccb36ed44308c79af750fce83ff
Autor:
Yingling Zu, Huifang Zhao, Jianling Chen, Huibing Dang, Yanrong Shi, Lixin Liang, Shuhao Mei, Yongping Song, Yanli Zhang
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-3 (2024)
Abstract Unintended pregnancy for female patients with chronic myeloid leukemia (CML) raises the discussion of treatment choices due to the teratogenicity of tyrosine kinase inhibitor (TKI). We report 51 accidental pregnant CML chronic phase (CP) pat
Externí odkaz:
https://doaj.org/article/887b412888ba496abb37888ec19c5403
Autor:
Ruirui Gui, Zhen Li, Juan Wang, Yingling Zu, Binglei Zhang, Juanjuan Zhao, Yongping Song, Jian Zhou
Publikováno v:
Heliyon, Vol 10, Iss 22, Pp e40356- (2024)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective measure for the treatment of hematological disease. With the progress and wide use of allo-HSCT, post-transplant central nervous system complications (CNSC) have gotten mo
Externí odkaz:
https://doaj.org/article/3c193627567d4357958c6642b5f3b854
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: Late acute graft-versus-host disease (aGVHD) is a complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with little data regarding treatment and outcomes. There is no standard treatment for gastrointestinal (GI) l
Externí odkaz:
https://doaj.org/article/15177c9b772a44a6b8be8db9de5c3483
Autor:
Quan Ren, Yingling Zu, Hongchang Su, Qiumei Lu, Bin Xiang, Yanping Luo, Jishuai Zhang, Yongping Song
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-4 (2023)
Abstract Natural killer (NK) cells are promising alternatives for the production of “off-the-shelf” CAR products, posing a lower risk of cytokine release syndrome (CRS) than CAR-T cells. We synthesized four single VHH-directed anti-BCMA CARs, inc
Externí odkaz:
https://doaj.org/article/9450c5a322df44c1ae46c663a6c42ccb
Autor:
Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Huifang Zhao, Xinrong Zhan, Zhongliang Wang, Pengtao Xing, Xianjing Wang, Huili Wang, Yongping Song, Jian Zhou
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/45f1047320724dd08b1f8cf45a664e4a
Autor:
Meijie He, Ruirui Gui, Yingling Zu, Zhen Li, Dao Wang, Yanna Mao, Xianjing Wang, Huili Wang, Yongping Song, Jian Zhou
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract Severe aplastic anemia (SAA) is a life-threatening hematological disorder. The major therapies include matched sibling donor (MSD)- hematopoietic stem cell transplantation (HSCT), matched unrelated donor (MUD)-HSCT and immunosuppressive ther
Externí odkaz:
https://doaj.org/article/e57a22e7e8f24277a4d874b22ef32ff7
Autor:
Zhenghua Huang, Zhen Li, Juan Wang, Ruirui Gui, Yingling Zu, Fengkuan Yu, Quande Lin, Huifang Zhao, Yanli Zhang, Baijun Fang, Yanyan Liu, Keshu Zhou, Yufu Li, Yuewen Fu, Zhihua Yao, Yongping Song, Jian Zhou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundWhether autologous hematopoietic stem cell transplantation (ASCT) improves the survival of patients with peripheral T-cell lymphoma (PTCL) remains controversial. Some studies have demonstrated that the efficacy of ASCT is superior in patien
Externí odkaz:
https://doaj.org/article/8053a24ad1f0496298eaa9357a9c34ca
Autor:
Lu Han, Ran Zhao, Jingyi Yang, Yingling Zu, Yanyan Liu, Jian Zhou, Linlin Li, Zhenghua Huang, Jishuai Zhang, Quanli Gao, Yongping Song, Keshu Zhou
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundConsolidative allogeneic hematopoietic stem cells (allo-HSCs) after chimeric antigen receptor T cells (CAR-T) therapy is an emerging modality in hematologic malignancies. Knowledge about the success of allogeneic hematopoietic stem cell tra
Externí odkaz:
https://doaj.org/article/781920305e1f4fd5b0ab5a37b63de028
Autor:
Binglei Zhang, Lingyun Chen, Jian Zhou, Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Fengkuan Yu, Yanli Zhang, Huifang Zhao, Zhenyu Ji, Yongping Song
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract This study aimed to observe the safety and clinical efficacy of early application of ruxolitinib to prevent acute graft-versus-host disease (aGVHD) after alternative donor transplantation in acute leukemia. There were 57 patients undergoing
Externí odkaz:
https://doaj.org/article/5eb65bd70e574ceb9712c6801b7e4352